New Key Statistics Module, Z-Score and F-Score
AMEX:ASXC Key Ratios
| Market Cap $ M | 90.41 |
| Enterprise Value $ M | 61.41 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 6.64 |
| Price/Sales | 9.77 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 8.00 |
| EPS (TTM) $ | -0.30 |
| Beneish M-Score | -4.48 |
| 10-y EBITDA Growth Rate % | 37.30 |
| 5-y EBITDA Growth Rate % | 47.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.83 |
| EV-to-EBITDA | -0.87 |
| PEG | -- |
| Shares Outstanding M | 272.33 |
| Net Margin (%) | -902.25 |
| Operating Margin % | -848.71 |
| Pre-tax Margin (%) | -899.16 |
| Quick Ratio | 0.69 |
| Current Ratio | 1.00 |
| ROA % (ttm) | -113.90 |
| ROE % (ttm) | -167.54 |
| ROIC % (ttm) | -223.33 |
| Dividend Yield % | -- |
| Altman Z-Score | -37.74 |
ASXC Number of Guru Trades
ASXC Volume of Guru Trades
Gurus Latest Trades with AMEX:ASXC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:ASXC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Asensus Surgical Inc Insider Transactions
No Available Data
News about AMEX:ASXC
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers